Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry

BACKGROUND: Treatment of hereditary angioedema (HAE) in ‘older adults’ (those aged ≥65 years) has not been well studied. The international Berinert Patient Registry collected data on the use of intravenous plasma-derived, pasteurized, nanofiltered C1-inhibitor concentrate (pnfC1-INH; Berinert(®)/CSL...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs Aging
Autores principales: Bygum, Anette, Martinez-Saguer, Inmaculada, Bas, Murat, Rosch, Jeffrey, Edelman, Jonathan, Rojavin, Mikhail, Williams-Herman, Debora
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5107191/
https://ncbi.nlm.nih.gov/pubmed/27699634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-016-0403-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares